Efficacy and Safety in a Randomised Acute Pain Study of MR308: STARDOM2.

NCT03062644 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1138

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Pain

Interventions

DRUG: MR308
DRUG: MR308
DRUG: MR308
DRUG: MR308

Sponsor

Mundipharma Research GmbH & Co KG